Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lemaitre Vascular (NQ: LMAT )

65.83 +0.89 (+1.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 209,365
Open 65.22
Bid (Size) 64.07 (1)
Ask (Size) 66.99 (1)
Prev. Close 64.94
Today's Range 65.14 - 66.14
52wk Range 40.82 - 68.06
Shares Outstanding 22,156,519
Dividend Yield 0.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is This Healthcare Stock a Buy for Dividend Growth Investors?
This medical device maker has crushed the S&P 500 index in the past 10 years. 
Via The Motley Fool
Why Shares of LeMaitre Vascular Are Up Wednesday
LeMaitre announced first-quarter earnings and guidance numbers. 
Via The Motley Fool

Performance

YTD
+44.90%
+44.90%
1 Month
+0.52%
+0.52%
3 Month
+34.90%
+34.90%
6 Month
+41.54%
+41.54%
1 Year
+42.37%
+42.37%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
Via Benzinga
Recap: LeMaitre Vascular Q1 Earnings
Via Benzinga
The Best Dividend Achievers
Via Talk Markets
Buy This Under-the-Radar Stock for Dividend Growth
Via The Motley Fool
Is This Small-Cap Dividend Stock a Buy?
Via The Motley Fool
Is This Underfollowed Dividend Stock a Buy?
Via The Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years
Via The Motley Fool
Weibo, XPeng, Li Auto And Other Big Losers From Friday
Via Benzinga
6 Overlooked Dividend Stocks For Your Buy List
Via Talk Markets
Earnings Scheduled For February 23, 2023
Via Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks Boast Midday Gains On Road To Big Weekly Weekly Wins
Via Talk Markets
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
Via Benzinga
High Growth Potential Small-Cap Dividend Stock Ideas [Podcast]
Via Talk Markets
Recap: LeMaitre Vascular Q4 Earnings
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
Why You Should Consider Buying This Little-Known Medical Devices Stock
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.